메뉴 건너뛰기




Volumn 68, Issue 1, 2008, Pages 105-122

Parnaparin: A review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disorders

Author keywords

Adis Drug Evaluations; Coronary artery disease; Parnaparin sodium, general; Peripheral arterial occlusive disorders; Venous insufficiency; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A; FIBRIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PARNAPARIN; PLACEBO; PROTHROMBIN A; UROKINASE;

EID: 37249092150     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200868010-00007     Document Type: Review
Times cited : (12)

References (62)
  • 1
    • 24944531701 scopus 로고    scopus 로고
    • Inhibition of factor Xa: A potential target for the development of new anticoagulants
    • Alexander JH, Singh KP. Inhibition of factor Xa: a potential target for the development of new anticoagulants. Am J Cardiovasc Drug 2005; 5 (5): 279-90
    • (2005) Am J Cardiovasc Drug , vol.5 , Issue.5 , pp. 279-290
    • Alexander, J.H.1    Singh, K.P.2
  • 2
    • 25444502110 scopus 로고    scopus 로고
    • Chronic venous disease and the leukocyte endothelium interaction: From symptoms to ulceration
    • Nicolaides AN. Chronic venous disease and the leukocyte endothelium interaction: from symptoms to ulceration. Angiology 2005; 56 Suppl. 1: S11-9
    • (2005) Angiology , vol.56 , Issue.SUPPL. 1
    • Nicolaides, A.N.1
  • 3
    • 3142720666 scopus 로고    scopus 로고
    • Treatment of deep-vein thrombosis
    • Jul 15;
    • Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med 2004 Jul 15; 351 (3): 268-77
    • (2004) N Engl J Med , vol.351 , Issue.3 , pp. 268-277
    • Bates, S.M.1    Ginsberg, J.S.2
  • 4
    • 0038380256 scopus 로고    scopus 로고
    • The epidemiology of venous thromboembolism
    • White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8
    • (2003) Circulation , vol.107
    • White, R.H.1
  • 5
    • 4644288189 scopus 로고    scopus 로고
    • Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Anti- thrombotic and Thrombolytic Therapy. Chest 2004 Sep; 126 (3 Suppl.): 338-400S
    • Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Anti- thrombotic and Thrombolytic Therapy. Chest 2004 Sep; 126 (3 Suppl.): 338-400S
  • 6
    • 37249019232 scopus 로고    scopus 로고
    • MedlinePlus Medical Encyclopedia. Unstable angina [online]. Available from URL: http://www.nlm.nih.gov/medlineplus/ency/article/000201.htm [Accessed 2006 Nov 23]
    • MedlinePlus Medical Encyclopedia. Unstable angina [online]. Available from URL: http://www.nlm.nih.gov/medlineplus/ency/article/000201.htm [Accessed 2006 Nov 23]
  • 7
    • 0031933561 scopus 로고    scopus 로고
    • Low-molecular-weight heparins for acute coronary syndromes
    • Spinler SA, Nawarskas JJ. Low-molecular-weight heparins for acute coronary syndromes. Ann Pharmacother 1998; 32 (1): 103-10
    • (1998) Ann Pharmacother , vol.32 , Issue.1 , pp. 103-110
    • Spinler, S.A.1    Nawarskas, J.J.2
  • 8
    • 0021962018 scopus 로고
    • The prevalence of peripheral arterial disease in a defined population
    • Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71 (3): 510-5
    • (1985) Circulation , vol.71 , Issue.3 , pp. 510-515
    • Criqui, M.H.1    Fronek, A.2    Barrett-Connor, E.3
  • 9
    • 0028890284 scopus 로고
    • Parnaparin: A review of its pharmacological profile and clinical application
    • Dettori AG. Parnaparin: a review of its pharmacological profile and clinical application. Drugs Today 1995; 31 (1): 19-35
    • (1995) Drugs Today , vol.31 , Issue.1 , pp. 19-35
    • Dettori, A.G.1
  • 10
    • 0031731396 scopus 로고    scopus 로고
    • The use of low-molecular-weight heparins in cardiovascular disease
    • Verhaeghe R. The use of low-molecular-weight heparins in cardiovascular disease. Acta Cardiol 1998; 53 (1): 15-21
    • (1998) Acta Cardiol , vol.53 , Issue.1 , pp. 15-21
    • Verhaeghe, R.1
  • 11
    • 0033817335 scopus 로고    scopus 로고
    • Comparative pharmacokinetics of LMWHs
    • Samama MM, Gerotziafas GT. Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost 2000; 26 (3 Suppl. 1): 31-8
    • (2000) Semin Thromb Hemost , vol.26 , Issue.3 SUPPL. 1 , pp. 31-38
    • Samama, M.M.1    Gerotziafas, G.T.2
  • 12
    • 11144352753 scopus 로고    scopus 로고
    • Generic low-molecular-weight heparins: Some practical considerations
    • Dec;
    • Fareed J, Leong WL, Hoppensteadt DA, et al. Generic low-molecular-weight heparins: some practical considerations. Semin Thromb Hemost 2004 Dec; 30 (6): 703-13
    • (2004) Semin Thromb Hemost , vol.30 , Issue.6 , pp. 703-713
    • Fareed, J.1    Leong, W.L.2    Hoppensteadt, D.A.3
  • 13
    • 0028349245 scopus 로고
    • Parnaparin: A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders
    • Apr;
    • Frampton JE, Faulds D. Parnaparin: a review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders. Drugs 1994 Apr; 47: 652-76
    • (1994) Drugs , vol.47 , pp. 652-676
    • Frampton, J.E.1    Faulds, D.2
  • 14
    • 37249005458 scopus 로고    scopus 로고
    • Fluxum™: summary of product characteristics. Bologna: Alfa Wassermann, 2007
    • Fluxum™: summary of product characteristics. Bologna: Alfa Wassermann, 2007
  • 15
    • 21244480057 scopus 로고    scopus 로고
    • Prevention of platelet-polymorphonuclear leukocyte interactions: New clues to the antithrombotic properties of parnaparin, a low molecular weight heparin
    • Jun;
    • Maugeri N, de Gaetano G, Barbanti M, et al. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin. Haematologica 2005 Jun; 90 (6): 833-9
    • (2005) Haematologica , vol.90 , Issue.6 , pp. 833-839
    • Maugeri, N.1    de Gaetano, G.2    Barbanti, M.3
  • 16
    • 34250634775 scopus 로고    scopus 로고
    • Parnaparin, a low-molecular-weight heparin, prevents P-select-independent formation of platelet-leukocyte aggregates in human whole blood
    • Jun;
    • Maugeri N, Di Fabio G, Barbanti M, et al. Parnaparin, a low-molecular-weight heparin, prevents P-select-independent formation of platelet-leukocyte aggregates in human whole blood. Thromb Haemost 2007 Jun; 97 (6): 965-73
    • (2007) Thromb Haemost , vol.97 , Issue.6 , pp. 965-973
    • Maugeri, N.1    Di Fabio, G.2    Barbanti, M.3
  • 17
    • 0027213684 scopus 로고
    • Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects
    • Melandri G, Semprini F, Cervi V, et al. Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects. Am J Cardiol 1993; 72: 450-4
    • (1993) Am J Cardiol , vol.72 , pp. 450-454
    • Melandri, G.1    Semprini, F.2    Cervi, V.3
  • 18
    • 23044467243 scopus 로고    scopus 로고
    • Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins: Pharmacologic implications
    • Dec;
    • Florian-Kujawski M, Hoppensteadt D, Maddineni J, et al. Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins: pharmacologic implications. Int Angiol 2004 Dec; 23 (4): 346-54
    • (2004) Int Angiol , vol.23 , Issue.4 , pp. 346-354
    • Florian-Kujawski, M.1    Hoppensteadt, D.2    Maddineni, J.3
  • 19
    • 0024337044 scopus 로고
    • Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients
    • Jan;
    • Palareti G, Legnani C, Bianchini B, et al. Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients. Int Angiol 1989 Jan; 8 (1): 47-52
    • (1989) Int Angiol , vol.8 , Issue.1 , pp. 47-52
    • Palareti, G.1    Legnani, C.2    Bianchini, B.3
  • 20
    • 0023816509 scopus 로고
    • Clinical pharmacology of a new low molecular weight heparin (alfa LMWH-Fluxum)
    • Jul;
    • Dettori AG, Tagliaferri A, Dall'Aglio E, et al. Clinical pharmacology of a new low molecular weight heparin (alfa LMWH-Fluxum). Int Angiol 1988 Jul; 7 (3 Suppl.): 7-18
    • (1988) Int Angiol , vol.7 , Issue.3 SUPPL. , pp. 7-18
    • Dettori, A.G.1    Tagliaferri, A.2    Dall'Aglio, E.3
  • 21
    • 0023721636 scopus 로고
    • Low molecular weight heparins for long-term therapy of peripheral vascular disease
    • Di Stefano F, Giglio A, Vinci M, et al. Low molecular weight heparins for long-term therapy of peripheral vascular disease. Curr Ther Res 1988; 44 (1): 1-10
    • (1988) Curr Ther Res , vol.44 , Issue.1 , pp. 1-10
    • Di Stefano, F.1    Giglio, A.2    Vinci, M.3
  • 22
    • 0023489220 scopus 로고
    • Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery
    • Speziale F, Verardi S, Taurino M, et al. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery. Pharmatherapeutica 1988; 5 (4): 261-8
    • (1988) Pharmatherapeutica , vol.5 , Issue.4 , pp. 261-268
    • Speziale, F.1    Verardi, S.2    Taurino, M.3
  • 23
    • 0026519749 scopus 로고
    • Post-surgical deep vein thrombosis prevention: Evaluation of the risk/benefit ratio of fractionated and unfractionated heparin
    • Garcea D, Martuzzi F, Santelmo N, et al. Post-surgical deep vein thrombosis prevention: evaluation of the risk/benefit ratio of fractionated and unfractionated heparin. Curr Med Res Opin 1992; 12 (9): 572-83
    • (1992) Curr Med Res Opin , vol.12 , Issue.9 , pp. 572-583
    • Garcea, D.1    Martuzzi, F.2    Santelmo, N.3
  • 24
    • 0023772308 scopus 로고
    • The use of low molecular weight heparins for post-surgical deep vein thrombosis prevention in orthopaedic patients
    • Chiapuzzo E, Orengo GB, Ottria G, et al. The use of low molecular weight heparins for post-surgical deep vein thrombosis prevention in orthopaedic patients. J Int Med Res 1988; 16: 359-66
    • (1988) J Int Med Res , vol.16 , pp. 359-366
    • Chiapuzzo, E.1    Orengo, G.B.2    Ottria, G.3
  • 25
    • 37249031102 scopus 로고    scopus 로고
    • Pharmacodynamic of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: A prospective randomised study comparing two different doses of parnaparin [abstract no. P153]. Haematologica 2006; 91 Suppl. 2: 89. Plus poster
    • presented at the, Sep 14-17: Milan
    • Legnani C, Imberti D, Cini M, et al. Pharmacodynamic of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: a prospective randomised study comparing two different doses of parnaparin [abstract no. P153]. Haematologica 2006; 91 Suppl. 2: 89. Plus poster presented at the XIX Congress of the Italian Society for Studies on Hemostasis and Thrombosis; 2006 Sep 14-17: Milan
    • (2006) XIX Congress of the Italian Society for Studies on Hemostasis and Thrombosis
    • Legnani, C.1    Imberti, D.2    Cini, M.3
  • 26
    • 0026762621 scopus 로고
    • Effects of two dosages of subcutaneous low molecular weight heparin (parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction
    • May 1;
    • Melandri G, Branzi A, Semprini F, et al. Effects of two dosages of subcutaneous low molecular weight heparin (parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction. Thromb Res 1992 May 1; 66 (2-3): 141-50
    • (1992) Thromb Res , vol.66 , Issue.2-3 , pp. 141-150
    • Melandri, G.1    Branzi, A.2    Semprini, F.3
  • 27
    • 0026033543 scopus 로고
    • Efficacy of low-molecular-weight heparin in the management of intermittent claudication
    • Mannarino E, Pasqualini L, Innocente S, et al. Efficacy of low-molecular-weight heparin in the management of intermittent claudication. Angiology 1991; 42 (1): 1-7
    • (1991) Angiology , vol.42 , Issue.1 , pp. 1-7
    • Mannarino, E.1    Pasqualini, L.2    Innocente, S.3
  • 28
    • 0027446423 scopus 로고
    • Clinical assessment of low molecular weight heparin effects in peripheral vascular disease
    • Mar;
    • Calabro A, Piarulli F, Milan D, et al. Clinical assessment of low molecular weight heparin effects in peripheral vascular disease. Angiology 1993 Mar; 44: 188-95
    • (1993) Angiology , vol.44 , pp. 188-195
    • Calabro, A.1    Piarulli, F.2    Milan, D.3
  • 29
    • 33644671315 scopus 로고    scopus 로고
    • Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study
    • PRIME CARE Study Investigators Group
    • PRIME CARE Study Investigators Group. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study. Indian Heart J 2005; 57: 648-54
    • (2005) Indian Heart J , vol.57 , pp. 648-654
  • 30
    • 36148996461 scopus 로고    scopus 로고
    • Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction
    • Wang X-K, Zhang Y, Yang C-M, et al. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction. Clin Drug Invest 2006; 26 (6): 341-9
    • (2006) Clin Drug Invest , vol.26 , Issue.6 , pp. 341-349
    • Wang, X.-K.1    Zhang, Y.2    Yang, C.-M.3
  • 32
    • 1642477712 scopus 로고    scopus 로고
    • Low-molecular-weight heparins for the treatment of acute coronary syndromes
    • Wong GC, Giugliano RP. Low-molecular-weight heparins for the treatment of acute coronary syndromes. Semin Vasc Med 2003; 3 (4): 391-402
    • (2003) Semin Vasc Med , vol.3 , Issue.4 , pp. 391-402
    • Wong, G.C.1    Giugliano, R.P.2
  • 33
    • 0026711157 scopus 로고
    • Human pharmacology of a low-molecular-weight heparin (alfa-LMWH): An update
    • Jul;
    • Dettori AG, Babbini M. Human pharmacology of a low-molecular-weight heparin (alfa-LMWH): an update. Med Res Rev 1992 Jul; 12 (4): 373-89
    • (1992) Med Res Rev , vol.12 , Issue.4 , pp. 373-389
    • Dettori, A.G.1    Babbini, M.2
  • 34
    • 37249034342 scopus 로고
    • Influence of the administration site on the bioavailability of a new low molecular weight heparin administered by subcutaneous route. Aggiornamenti di Medicina e
    • Agrati AM, Ambrosi G, Spinelli G, et al. Influence of the administration site on the bioavailability of a new low molecular weight heparin administered by subcutaneous route. Aggiornamenti di Medicina e Chirurgia 1991; 9 (3): 375-9
    • (1991) Chirurgia , vol.9 , Issue.3 , pp. 375-379
    • Agrati, A.M.1    Ambrosi, G.2    Spinelli, G.3
  • 35
    • 0023682894 scopus 로고
    • Kinetic control in healthy volunteers of low molecular weight heparin antithrombotic activity
    • Palmieri GC, Ambrosi G, Ferrero G. Kinetic control in healthy volunteers of low molecular weight heparin antithrombotic activity. Riv Eur Sci Med Farmacol 1988; 10: 187-92
    • (1988) Riv Eur Sci Med Farmacol , vol.10 , pp. 187-192
    • Palmieri, G.C.1    Ambrosi, G.2    Ferrero, G.3
  • 36
    • 37249016611 scopus 로고
    • Pharmacodynamic properties of a new low moleular weight heparin, parnaparin [abstract no. 09]
    • Harenberg J. Pharmacodynamic properties of a new low moleular weight heparin, parnaparin [abstract no. 09]. Thromb Res 1993; 70 Suppl. 1: 162
    • (1993) Thromb Res , vol.70 , Issue.SUPPL. 1 , pp. 162
    • Harenberg, J.1
  • 37
    • 0023722567 scopus 로고
    • Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent postoperative deep venous thrombosis
    • Valle I, Sola G, Origone A. Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent postoperative deep venous thrombosis. Curr Med Res Opin 1988; 11 (2): 80-6
    • (1988) Curr Med Res Opin , vol.11 , Issue.2 , pp. 80-86
    • Valle, I.1    Sola, G.2    Origone, A.3
  • 38
    • 0024443327 scopus 로고
    • Low molecular weight heparin (alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures
    • Jul;
    • Pini M, Tagliaferri A, Manotti C, et al. Low molecular weight heparin (alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures. Int Angiol 1989 Jul; 8 (3): 134-9
    • (1989) Int Angiol , vol.8 , Issue.3 , pp. 134-139
    • Pini, M.1    Tagliaferri, A.2    Manotti, C.3
  • 39
    • 0027859071 scopus 로고
    • Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery
    • Beghi C, Fragnito C, Antonelli A, et al. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery. Int Angiol 1993; 12 (4): 383-6
    • (1993) Int Angiol , vol.12 , Issue.4 , pp. 383-386
    • Beghi, C.1    Fragnito, C.2    Antonelli, A.3
  • 40
    • 0023709245 scopus 로고
    • A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis
    • Jul;
    • Verardi S, Casciani CU, Nicora E, et al. A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis. Int Angiol 1988 Jul; 7 (3 Suppl.): 19-24
    • (1988) Int Angiol , vol.7 , Issue.3 SUPPL. , pp. 19-24
    • Verardi, S.1    Casciani, C.U.2    Nicora, E.3
  • 41
    • 0023923994 scopus 로고
    • Postsurgery thromboembolism prevention by LMW heparin subcutaneous administration
    • Mascali F, Condorelli A, Salanitiri G, et al. Postsurgery thromboembolism prevention by LMW heparin subcutaneous administration. Eur Rev Med Pharmacol Sci 1988; 10: 135-41
    • (1988) Eur Rev Med Pharmacol Sci , vol.10 , pp. 135-141
    • Mascali, F.1    Condorelli, A.2    Salanitiri, G.3
  • 42
    • 34347212202 scopus 로고    scopus 로고
    • Clinical experience with parnaparin in orthopedic surgery
    • Bandiera S, Casalini D, Friemel P, et al. Clinical experience with parnaparin in orthopedic surgery. Euro Bull Drug Res 2003; 11 (4): 77-91
    • (2003) Euro Bull Drug Res , vol.11 , Issue.4 , pp. 77-91
    • Bandiera, S.1    Casalini, D.2    Friemel, P.3
  • 43
    • 34347223237 scopus 로고    scopus 로고
    • Prophylaxis of venous thromboembolism in minor orthopedic surgery with parnaparin
    • Montebugnoli M, Bugamelli S, Calo P, et al. Prophylaxis of venous thromboembolism in minor orthopedic surgery with parnaparin. Clin Appl Thromb Hemost 2007; 13 (3): 249-58
    • (2007) Clin Appl Thromb Hemost , vol.13 , Issue.3 , pp. 249-258
    • Montebugnoli, M.1    Bugamelli, S.2    Calo, P.3
  • 44
    • 0023787086 scopus 로고
    • Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebytic syndrome: LMW-heparin versus standard heparin
    • Verardi S, Ippoliti A, Pistolese GR. Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebytic syndrome: LMW-heparin versus standard heparin. Int Angiol 1988; 7 Suppl. 3: 33-40
    • (1988) Int Angiol , vol.7 , Issue.SUPPL. 3 , pp. 33-40
    • Verardi, S.1    Ippoliti, A.2    Pistolese, G.R.3
  • 45
    • 0024953575 scopus 로고
    • Antithrombotic therapy in phlebopathies of lower limbs: A controlled study of low molecular weight heparin versus heparin calcium
    • Luttichau U, Palazzini E. Antithrombotic therapy in phlebopathies of lower limbs: a controlled study of low molecular weight heparin versus heparin calcium. Eur Rev Med Pharmacol Sci 1989; 11: 351-8
    • (1989) Eur Rev Med Pharmacol Sci , vol.11 , pp. 351-358
    • Luttichau, U.1    Palazzini, E.2
  • 46
    • 0027817086 scopus 로고
    • Low molecular weight heparins in chronic venous insufficiency: Controlled trial of parnaparin efficacy and tolerability
    • Della Marchina M, Renzi G, Renzi C, et al. Low molecular weight heparins in chronic venous insufficiency: controlled trial of parnaparin efficacy and tolerability. Br J Clin Res 1993; 4: 29-36
    • (1993) Br J Clin Res , vol.4 , pp. 29-36
    • Della Marchina, M.1    Renzi, G.2    Renzi, C.3
  • 47
    • 37249006938 scopus 로고
    • Medium term treatment of thrombotic pathologies of the lower limbs with a new LMW heparin
    • Mangialardi N, Matteoni R, Serrao E, et al. Medium term treatment of thrombotic pathologies of the lower limbs with a new LMW heparin. Medical Praxis 1991; 12: 1-7
    • (1991) Medical Praxis , vol.12 , pp. 1-7
    • Mangialardi, N.1    Matteoni, R.2    Serrao, E.3
  • 48
    • 37249051051 scopus 로고
    • Heparin therapy of post-phlebitic syndrome: Results of a single-blind, clinical trial of parnaparin vs calcium heparin
    • Catania G, Salanitri T. Heparin therapy of post-phlebitic syndrome: results of a single-blind, clinical trial of parnaparin vs calcium heparin. Stampa Medica Europea 1993; 13: 17-27
    • (1993) Stampa Medica Europea , vol.13 , pp. 17-27
    • Catania, G.1    Salanitri, T.2
  • 49
    • 0024693905 scopus 로고
    • Low molecular weight heparin in the symptomatic treatment of chronic venous insufficiency: Controlled double blind study vs calcium heparin
    • Sannazzari P. Low molecular weight heparin in the symptomatic treatment of chronic venous insufficiency: controlled double blind study vs calcium heparin. Panminerva Med 1989; 31 (3): 127-33
    • (1989) Panminerva Med , vol.31 , Issue.3 , pp. 127-133
    • Sannazzari, P.1
  • 50
    • 34250712893 scopus 로고    scopus 로고
    • Home therapy with LMWH in deep vein thrombosis: Randomized study comparing single and double daily administrations
    • Bellosta R, Ferrari P, Luzzani L, et al. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations. Angiology 2007; 58 (3): 316-22
    • (2007) Angiology , vol.58 , Issue.3 , pp. 316-322
    • Bellosta, R.1    Ferrari, P.2    Luzzani, L.3
  • 51
    • 0027527203 scopus 로고
    • Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris: A double-blind, randomized, placebo-controlled trial
    • Melandri G, Semprini F, Cervi V, et al. Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris: a double-blind, randomized, placebo-controlled trial. Circulation 1993; 88: 2517-23
    • (1993) Circulation , vol.88 , pp. 2517-2523
    • Melandri, G.1    Semprini, F.2    Cervi, V.3
  • 52
    • 0027467042 scopus 로고
    • Low molecular weight heparins: Therapeutic insight in peripheral arterial occlusive disease
    • Apr;
    • Simoni G, Lucertini G, Decian F. Low molecular weight heparins: therapeutic insight in peripheral arterial occlusive disease. Clin Trials Metaanal 1993 Apr; 28: 137-45
    • (1993) Clin Trials Metaanal , vol.28 , pp. 137-145
    • Simoni, G.1    Lucertini, G.2    Decian, F.3
  • 53
    • 0023763318 scopus 로고
    • A new low molecular weight heparin in the treatment of peripheral arterial disease
    • Palmieri G, Ambrosi G, Agrati AM, et al. A new low molecular weight heparin in the treatment of peripheral arterial disease. Int Angiol 1988; 7 Suppl. 3: 41-7
    • (1988) Int Angiol , vol.7 , Issue.SUPPL. 3 , pp. 41-47
    • Palmieri, G.1    Ambrosi, G.2    Agrati, A.M.3
  • 54
    • 27644563148 scopus 로고    scopus 로고
    • The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: A prospective cohort study
    • Nov 1;
    • Prandoni P, Siragusa S, Girolami B, et al. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Blood 2005 Nov 1; 106 (9): 3049-54
    • (2005) Blood , vol.106 , Issue.9 , pp. 3049-3054
    • Prandoni, P.1    Siragusa, S.2    Girolami, B.3
  • 55
    • 1642298343 scopus 로고    scopus 로고
    • Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: A literature review
    • Messmore HL, Coyne E, Wehrmacher WH, et al. Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature review. Curr Pharm Des 2004; 10 (9): 1001-10
    • (2004) Curr Pharm Des , vol.10 , Issue.9 , pp. 1001-1010
    • Messmore, H.L.1    Coyne, E.2    Wehrmacher, W.H.3
  • 56
    • 33644645358 scopus 로고    scopus 로고
    • Guidelines on the use and monitoring of heparin. The British Committee for Standards in Haematology
    • Baglin T, Barrowcliffe TW, Cohen A, et al. Guidelines on the use and monitoring of heparin. The British Committee for Standards in Haematology. Br J Haematol 2006; 133 (1): 19-34
    • (2006) Br J Haematol , vol.133 , Issue.1 , pp. 19-34
    • Baglin, T.1    Barrowcliffe, T.W.2    Cohen, A.3
  • 57
    • 2342621534 scopus 로고    scopus 로고
    • Treatment of venous thromboembolism with low-molecular-weight heparin: A synthesis of the evidence published in systematic literature reviews
    • Krishnan JA, Segal JB, Streiff MB, et al. Treatment of venous thromboembolism with low-molecular-weight heparin: a synthesis of the evidence published in systematic literature reviews. Respir Med 2004; 98 (5): 376-86
    • (2004) Respir Med , vol.98 , Issue.5 , pp. 376-386
    • Krishnan, J.A.1    Segal, J.B.2    Streiff, M.B.3
  • 58
    • 33644877317 scopus 로고    scopus 로고
    • Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: A meta-analysis of the randomised trials
    • Eikelboom JW, Quinlan DJ, Mehta SR, et al. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomised trials. Circulation 2005; 112: 3855-67
    • (2005) Circulation , vol.112 , pp. 3855-3867
    • Eikelboom, J.W.1    Quinlan, D.J.2    Mehta, S.R.3
  • 59
    • 0029035681 scopus 로고
    • Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin
    • Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5
    • (1995) N Engl J Med , vol.332 , pp. 1330-1335
    • Warkentin, T.E.1    Levine, M.N.2    Hirsh, J.3
  • 60
    • 0032925807 scopus 로고    scopus 로고
    • Low-molecular weight heparins compared with unfractionated heparin for the treatment of acute deep venous thrombosis: A cost-effectiveness analysis
    • Gould MK, Dembitzer AD, Sanders GD, et al. Low-molecular weight heparins compared with unfractionated heparin for the treatment of acute deep venous thrombosis: a cost-effectiveness analysis. Ann Intern Med 1999; 130 (10): 789-99
    • (1999) Ann Intern Med , vol.130 , Issue.10 , pp. 789-799
    • Gould, M.K.1    Dembitzer, A.D.2    Sanders, G.D.3
  • 61
    • 37249021065 scopus 로고    scopus 로고
    • Parnaparin: Comparison with other low molecular weight heparins [in Italian]
    • Pradelli L. Parnaparin: comparison with other low molecular weight heparins [in Italian]. Farmeconomia e Percorsi Terapeutici 2005; 6 (3): 227-41
    • (2005) Farmeconomia e Percorsi Terapeutici , vol.6 , Issue.3 , pp. 227-241
    • Pradelli, L.1
  • 62
    • 24944495296 scopus 로고    scopus 로고
    • Fondaparinux sodium: A review of its use in the treatment of acute venous thromboembolism
    • Robinson DM, Wellington K. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism. Am J Cardiovasc Drug 2005; 5 (5): 335-46
    • (2005) Am J Cardiovasc Drug , vol.5 , Issue.5 , pp. 335-346
    • Robinson, D.M.1    Wellington, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.